A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP-HepB-Hib vaccine in Indian infants

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 9, 2013, Pages 1903-1909

  Eregowda, Adarsh ^a   Lalwani, Sanjay ^b   Chatterjee, Sukanta ^c   Vakil, Hoshang ^d   Ahmed, Khaleel ^e   Costantini, Marco ^f   Lattanzi, Maria ^f  

^a Rajarajeshwari Medical College and Research Hospital   (India)

^b Bharati Vidyapeeth's Medical College   (India)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d Novartis Vaccines and Diagnostics   (India)

^e Novartis Vaccines and Diagnostics   (India)

^f NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Combination vaccine; DTwP HepB Hib; Fully liquid pentavalent vaccine; Immunogenicity; Infants; Safety

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE;

ANEMIA; ARTICLE; BLOOD SAMPLING; BRONCHOPNEUMONIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIPHTHERIA; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FEVER; GASTROESOPHAGEAL REFLUX; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INDIAN; INFANT; MALE; OUTCOME ASSESSMENT; PERTUSSIS; TETANUS; VACCINATION;

COMBINATION VACCINE; DTWP-HEPB-HIB; FULLY-LIQUID PENTAVALENT VACCINE; IMMUNOGENICITY; INFANTS; SAFETY;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ERYTHEMA; FEMALE; FEVER; HAEMOPHILUS VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INDIA; INFANT; MALE; VACCINATION;

EID: 84884649677     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.25166     Document Type: Article

References (26)

1. IAP Committee on Immunization 2009-2011. In: Yewale V, Choudhury P, Thacker N, ed(s). IAP guidebook on immunization, Mumbai: Indian Academy of Pediatrics, 2011:1-180.
2. Combination vaccines for childhood immunization. MMWR Recomm Rep 1999; 48(RR-5):1-14; PMID:10353568
3. Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP). Pediatrics 1999; 103:1064-77; PMID:10224194; http://dx.doi.org/10.1542/peds.103. 5.1064
4. Schmid DA, Macura-Biegun A, Rauscher M. Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries-Quinvaxem®: the first 5 years. Vaccine 2012; 30:6241-8; PMID:22889824; http://dx.doi.org/10.1016/j.vaccine.2012.07.088
5. World Health Organization. WHO Prequalified Vaccines, Available at: http://www.who.int/immunization-standards/vaccine-quality/PQ-vaccine-list-en/en/ Accessed Nov 20, 2012.
6. Botet Asensi FI, Veronese A, Del Carmen Otero M, Desamparados Tamarit Pérez M, Hontangas Lopez JL, Viviani S. Immunogenicity and safety in infants of a DTwPHib full liquid vaccine. Acta Paediatr 2003; 92:541-5; PMID:12839281; http://dx.doi.org/10.1111/j.1651-2227.2003.tb02503.x
7. Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, et al. Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. Hum Vaccin 2006; 2:155-60; PMID:17012890; http://dx.doi.org/10.4161/hv.2.4.2942
8. Tamm E, Veronese A, Contorni M, Meriste S, Nacci P, Viviani S. Double-blind study comparing the immunogenicity of a licensed DTwPHib-CRM197 conjugate vaccine (Quattvaxem) with three investigational, liquid formulations using lower doses of Hib-CRM197 conjugate. Vaccine 2005; 23:1715-9; PMID:15705477; http://dx.doi.org/10.1016/j.vaccine.2004.09.028
9. Suárez E, Asturias EJ, Hilbert AK, Herzog C, Aeberhard U, Spyr C. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador. Rev Panam Salud Publica 2010; 27:117-24; PMID:20339615; http://dx.doi.org/10.1590/S1020-49892010000200005
10. Aspinall S, Traynor D, Bedford P, Hartmann K. Lotto-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem (®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine. Hum Vaccin Immunother 2012; 8:1109-18; PMID:22854660; http://dx.doi.org/10.4161/hv.21095
11. Gentile A, Umido V, Czerniuk P, Nacul J, Seigelchifer M, Hilbert AK, et al. Immunogenicity and reactogenicity of a combined fully liquid DTPw-HepB-Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine. Int J Infect Dis 2011; 15:e24-9; PMID:21093342; http://dx.doi.org/10.1016/j.ijid.2010.09.004
12. Sharma H, Yadav S, Lalwani S, Gupta V, Kapre S, Jadhav S, et al. A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw-HBV-Hib, a liquid pentavalent vaccine in Indian infants. Vaccine 2011; 29:2359-64; PMID:21288803; http://dx.doi.org/10.1016/j.vaccine.2011.01.054
13. Sharma HJ, Yadav S, Lalwani SK, Kapre SV, Jadhav SS, Chakravarty A, et al. Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. Hum Vaccin 2011; 7:451-7; PMID:21403463; http://dx.doi.org/10.4161/hv.7.4.14208
14. Chatterjee S, Rego SJ, D'Souza F, Bhatia BD, Collard A, Datta SK, et al. The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule. BMC Infect Dis 2010; 10:298; PMID:20950457; http://dx.doi.org/10.1186/1471-2334-10-298
15. Ali SS, Chandrashekar SR, Singh M, Bansal RK, Sharma DR, Arora D. A multicenter, prospective, open-label, non-comparative study to evaluate the immunogenicity and tolerance of a new, fully liquid pentavalent vaccine (DTwP-HepB-Hib vaccine). Hum Vaccin 2007; 3:116-20; PMID:17617743; http://dx.doi.org/10.4161/hv.3.4.4061
16. Bavdekar SB, Maiya PP, Subba Rao SD, Datta SK, Bock HL. Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B/Haemophilus influenzae type b vaccine in Indian infants. Indian Pediatr 2007; 44:505-10; PMID:17684303
17. Rao R, Dhingra MS, Bavdekar S, Behera N, Daga SR, Dutta AK, et al. A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHBHib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule. Hum Vaccin 2009; 5:425-9; PMID:19333002
18. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996; 174(Suppl 3):S259-63; PMID:8896526; http://dx.doi.org/10.1093/ infdis/174.Supplement-3.S259
19. World Health Organization (WHO). Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010; 85:385-400; PMID:20939150
20. Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012; 129:968-70; PMID:22529282; http://dx.doi.org/10.1542/peds.2011-2594
21. California Department of Public Health. Immunization Branch. Pertussis report. April 13, 2011. Available at: www.cdph.ca.gov. Accessed Nov 20, 2012.
22. Deinhardt F, Zuckerman AJ. Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. J Med Virol 1985; 17:209-17; PMID:4067587; http://dx.doi.org/10.1002/jmv.1890170302
23. von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, et al. European seroepidemiology network: standardisation of the results of diphtheria antitoxin assays. Vaccine 2000; 18:3287-96; PMID:10869774; http://dx.doi.org/10.1016/S0264-410X(00)00125-0
24. World Health Organization (WHO). The immunological basis for immunization series. module 3: Tetanus. 2006.
25. Mariani M, Luzzi E, Proietti D, Mancianti S, Casini D, Costantino P, et al. A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b. Clin Diagn Lab Immunol 1998; 5:667-74; PMID:9729534
26. Mertsola J, Ruuskanen O, Kuronen T, Meurman O, Viljanen MK. Serologic diagnosis of pertussis: evaluation of pertussis toxin and other antigens in enzyme-linked immunosorbent assay. J Infect Dis 1990; 161:966-71; PMID:2324547; http://dx.doi.org/10.1093/infdis/161.5.966